RecruitingNot ApplicableNCT06539806

Clinical Study Evaluating the Effect of Losartan

Clinical Study Evaluating the Effect of Losartan on Response Rate in Both Metastatic and Locally Advanced Pancreatic Cancer Patients


Sponsor

Tanta University

Enrollment

90 participants

Start Date

Jul 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The pancreas is two organs packaged into one. The islets of Langerhans serve critical endocrine functions, and the exocrine portion is a major source of enzymes that are essential for digestion. Pancreatic cancer (PC) is more commonly referred to as pancreatic infiltrating ductal adenocarcinoma in addition to being the second leading cause of cancer death in the United States, after lung cancer in 2020. Whereas pancreatic cancer is the seventh cause of death from cancer in Asia in 2020. Although it is substantially less common than the other malignancies, pancreatic carcinoma is near the top of the list of killers because it is a highly aggressive carry.


Eligibility

Min Age: 50 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying whether the blood pressure medication losartan can improve outcomes for people with pancreatic cancer. Lab research suggests that losartan may help chemotherapy drugs reach tumors more effectively. This trial combines losartan with standard chemotherapy to find out if this combination works better than chemotherapy alone. **You may be eligible if...** - You are 50 or older (male or female) with high blood pressure (BP ≥ 140/90) - You have been diagnosed with metastatic or locally advanced pancreatic cancer confirmed by tissue sample **You may NOT be eligible if...** - You have serious heart, kidney, liver, or lung disease - You are pregnant, breastfeeding, or of childbearing potential - You have received fluoropyrimidine-based chemotherapy (like 5-fluorouracil) in the past 10 years - You have had a severe reaction to fluoropyrimidine therapy or are allergic to its components Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLosartan 50mg Tab

The efficacy of losartan on response rate in both metastatic and locally advanced pancreatic cancer patients


Locations(1)

Tanta University Hospital

Tanta, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06539806


Related Trials